Development Level

Tbio 3 | 10,625
Tchem 3 | 1,890

IMPC Term

preweaning lethality, complete... 3 | 633
abnormal behavioral response t... 1 | 52
abnormal bone structure 1 | 131
decreased circulating glucose ... 1 | 121
embryonic lethality prior to o... 1 | 148
embryonic lethality prior to t... 1 | 187
increased exploration in new e... 1 | 56

Disease

ovarian cancer 5 | 8,484
Cancer 4 | 2,346
osteosarcoma 4 | 7,933
Ataxia telangiectasia 2 | 31
Bloom syndrome 2 | 30
Carcinoma 2 | 2,147
Microcephaly 2 | 149
Nijmegen breakage syndrome 2 | 23
Peripheral Neuropathy 2 | 303
Pick disease 2 | 1,893
Seckel syndrome 2 | 34
acute quadriplegic myopathy 2 | 1,157
astrocytic glioma 2 | 2,241
colon cancer 2 | 1,475
lung cancer 2 | 4,466
malignant mesothelioma 2 | 3,162
non primary Sjogren syndrome sicca 2 | 840
Adenoid Cystic Carcinoma 1 | 99
Ataxia-Telangiectasia Variant 1 | 1
Bacillary angiomatosis 1 | 7
Bladder Neoplasm 1 | 109
Breast Cancer, Familial 1 | 12
Breast cancer 1 | 3,094
CUTANEOUS TELANGIECTASIA AND CANCER SYNDROME, FAMILIAL 1 | 1
Cardiomyopathy, Dilated 1 | 47
Cataract 1 | 104
Cerebellar Ataxia 1 | 72
Chronic Lymphocytic Leukemia 1 | 242
DNA ligase IV deficiency 1 | 6
Dengue disease 1 | 19
Fanconi's anemia 1 | 50
Fibrosis 1 | 40
Immune system cancer 1 | 38
Intellectual disability 1 | 573
Israeli tick typhus 1 | 2
Kidney cancer 1 | 118
Liver Cirrhosis 1 | 101
Liver carcinoma 1 | 217
Lymphoid leukemia 1 | 69
Lymphoma, T-Cell, Cutaneous 1 | 21
MHC class II deficiency 1 | 2
Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse 1 | 12
Mammary Neoplasms 1 | 410
Mantle cell lymphoma 1 | 18
Melanoma 1 | 261
Multiple Sclerosis 1 | 498
Myocardial Infarction 1 | 126
Neoplasms, Second Primary 1 | 6
Neoplastic Syndromes, Hereditary 1 | 48
Neurodegenerative disease 1 | 383
Pancreatic Neoplasm 1 | 79
Peripheral T-cell lymphoma 1 | 24
Pneumoconiosis 1 | 14
Prenatal Exposure Delayed Effects 1 | 9
Prostatic Neoplasms 1 | 471
Stomach Neoplasms 1 | 282
T-Cell Prolymphocytic Leukemia 1 | 1
Telangiectasis 1 | 20
Urologic Neoplasms 1 | 7
Ventricular Dysfunction, Left 1 | 15
Werner syndrome 1 | 29
atypical teratoid/rhabdoid tumor 1 | 1,095
dermatomyositis 1 | 933
diabetes mellitus 1 | 1,663
ependymoma 1 | 2,514
esophageal adenocarcinoma 1 | 737
glioblastoma 1 | 5,572
group 3 medulloblastoma 1 | 2,254
intraductal papillary-mucinous neoplasm (IPMN) 1 | 3,289
invasive ductal carcinoma 1 | 2,950
juvenile dermatomyositis 1 | 1,189
lung carcinoma 1 | 2,844
medulloblastoma, large-cell 1 | 6,234
non-small cell lung cancer 1 | 2,798
oligodendroglioma 1 | 2,849
pituitary cancer 1 | 1,972
progressive supranuclear palsy 1 | 674
psoriasis 1 | 6,685
sonic hedgehog group medulloblastoma 1 | 1,482
tuberculosis and treatment for 6 months 1 | 686
ulcerative colitis 1 | 2,087

Tissue

Blood and immune system 6 | 17,995
Cardiovascular System 6 | 17,958
Digestive Tract 6 | 18,473
Endocrine System 6 | 18,512
Female tissues 6 | 18,647
Liver and Pancreas 6 | 18,136
Male tissues 6 | 17,969
Nervous System 6 | 18,561
Respiratory system 6 | 17,484
Skin and soft tissues 6 | 18,115
Urinary Tract 6 | 18,444

Target Family

Non-IDG 4 | 11,971
Kinase 2 | 634

Grant Application

5R01CA076172-07 6 | 6
3P41RR001209-23S1 157 | 157
5P41RR001209-22 157 | 157
5P41RR001209-23 157 | 157
2P51RR000165-51 139 | 139
5P51RR000163-52 136 | 136
5P51RR000163-51 132 | 132
5P51RR000165-50 130 | 130
2P51RR000163-50 128 | 128
5P51RR000164-48 127 | 127
5P51RR000164-50 125 | 125
5P51RR000164-49 112 | 112
5P51RR000165-49 106 | 106
5P41RR001646-19 103 | 103
5P41RR001646-20 103 | 103
7P51RR000163-41 100 | 100
2P41RR011823-16 99 | 99
5P51RR000163-42 98 | 98
5P51RR000163-43 98 | 98
5P41RR001081-24 94 | 94
5P41RR001646-18 90 | 90
5P41RR015301-09 82 | 82
5P51RR000167-49 78 | 78
5P41RR002250-26 65 | 65
5P51RR000168-40 65 | 65
5P51RR000168-41 65 | 65
5P41RR001646-27 64 | 64
5P51RR000165-40 63 | 63
5M01RR000188-45 60 | 60
3P41RR010888-05S1 59 | 59
5M01RR000030-40 58 | 58
5M01RR000096-39 57 | 57
5P41RR000954-25 57 | 57
5P41RR000954-26 57 | 57
2P41RR000954-33 56 | 56
5P41RR010888-14 56 | 56
5P41RR012408-13 55 | 55
5M01RR000188-46 53 | 53
5P41RR001646-28 52 | 52
5P51RR000167-48 52 | 52
5P51RR000168-49 52 | 52
5P41RR001646-29 51 | 51
2P41RR002250-25 50 | 50
5M01RR000188-47 50 | 50
5P51RR000166-39 47 | 47
5M01RR000043-40 46 | 46
5P51RR000168-50 46 | 46
5P41RR010888-15 45 | 45
5P41RR015301-08 45 | 45
5P41RR004050-13 44 | 44
5M01RR000847-37 43 | 43
5P41RR004050-12 43 | 43
5P51RR000167-50 43 | 43
5P51RR000169-50 43 | 43
5P41RR000954-34 42 | 42
2P41RR004050-21 41 | 41
5P41RR010888-13 41 | 41
5P51RR000168-48 41 | 41
5P51RR000167-40 40 | 40
5P41RR015301-07 39 | 39
5P51RR000164-39 39 | 39
5P51RR000168-39 39 | 39
2P51RR000169-49 38 | 38
5P51RR000169-48 38 | 38
5P41RR004050-23 37 | 37
5P51RR013986-13 37 | 37
3P51RR000167-46S2 36 | 36
5P41RR001008-25 36 | 36
5M01RR000043-49 35 | 35
5P20RR021905-04 35 | 35
5P41RR004050-22 35 | 35
5M01RR000040-40 34 | 34
5P20RR016481-10 34 | 34
5P41RR001315-19 34 | 34
3P60DE013079-01S1 32 | 32
5M01RR000833-26 32 | 32
5P20RR016481-11 32 | 32
5P20RR020152-07 32 | 32
5P41RR000862-38 32 | 32
5P51RR000166-49 32 | 32
5P60DE013079-02 32 | 32
5S06GM008037-29 32 | 32
5S06GM008037-30 32 | 32
5U41RR007707-10 32 | 32
2P20RR016480-09 31 | 31
5M01RR000827-34 31 | 31
5P41RR002250-24 31 | 31
5P41RR005959-22 31 | 31
5P41RR018522-08 31 | 31
3P60DE013079-03S1 30 | 30
5P20RR016457-10 30 | 30
5P41RR000592-40 30 | 30
5P41RR000592-41 30 | 30
5P41RR000862-36 30 | 30
5P41RR007707-17 30 | 30
5P51RR000166-48 30 | 30
5P60DE013079-03 30 | 30
5P60DE013079-04 30 | 30
5U54AI057168-09 30 | 30
5U54AI057168-10 30 | 30
2U54AI057168-06 29 | 29

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Serine/threonine-protein kinase ATR ATR Tchem Kinase -2.76182 513.9 350
Cell cycle checkpoint control protein RAD9A RAD9A Tbio Non-IDG -2.13903 136.3 864
Cell cycle checkpoint protein RAD17 RAD17 Tbio Non-IDG -2.05235 111.4 432
Checkpoint protein HUS1 HUS1 Tbio Non-IDG -1.86001 66.4 154
Serine-protein kinase ATM ATM Tchem Kinase -3.52076 3417.4 954
Cell cycle checkpoint protein RAD1 RAD1 Tchem Non-IDG -1.99891 98.1 211